153 related articles for article (PubMed ID: 27745912)
41. Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy.
Rudzianskas V; Inciura A; Juozaityte E; Rudzianskiene M; Kubilius R; Vaitkus S; Kaseta M; Adliene D
Acta Otorhinolaryngol Ital; 2012 Oct; 32(5):297-303. PubMed ID: 23326008
[TBL] [Abstract][Full Text] [Related]
42. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
43. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
44. High-dose-rate and pulsed-dose-rate brachytherapy in palliative treatment of head and neck cancers.
Bartochowska A; Wierzbicka M; Skowronek J; Leszczyńska M; Szyfter W
Brachytherapy; 2012; 11(2):137-43. PubMed ID: 22104354
[TBL] [Abstract][Full Text] [Related]
45. High-dose reirradiation of head and neck cancer with curative intent.
Stevens KR; Britsch A; Moss WT
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):687-98. PubMed ID: 8040014
[TBL] [Abstract][Full Text] [Related]
46. Phase II trial of image-based high-dose-rate interstitial brachytherapy for previously irradiated gynecologic cancer.
Martínez-Monge R; Cambeiro M; Rodríguez-Ruiz ME; Olarte A; Ramos LI; Villafranca E; Bascón N; Jurado M
Brachytherapy; 2014; 13(3):219-24. PubMed ID: 24559794
[TBL] [Abstract][Full Text] [Related]
47. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
[TBL] [Abstract][Full Text] [Related]
48. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
49. Reirradiation of head and neck cancer: Long-term disease control and toxicity.
Bots WTC; van den Bosch S; Zwijnenburg EM; Dijkema T; van den Broek GB; Weijs WLJ; Verhoef LCG; Kaanders JHAM
Head Neck; 2017 Jun; 39(6):1122-1130. PubMed ID: 28263446
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
[TBL] [Abstract][Full Text] [Related]
51. Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases.
Teudt IU; Kovàcs G; Ritter M; Melchert C; Soror T; Wollenberg B; Meyer JE
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2707-15. PubMed ID: 26498949
[TBL] [Abstract][Full Text] [Related]
52. Reirradiation Using Permanent Interstitial Brachytherapy: A Potentially Durable Technique for Salvaging Recurrent Pelvic Malignancies.
Feddock J; Cheek D; Steber C; Edwards J; Slone S; Luo W; Randall M
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1225-1233. PubMed ID: 29029888
[TBL] [Abstract][Full Text] [Related]
53. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
[TBL] [Abstract][Full Text] [Related]
54. Intraoperative single fraction high-dose-rate brachytherapy for head and neck cancers.
Nag S; Koc M; Schuller DE; Tippin D; Grecula JC
Brachytherapy; 2005; 4(3):217-23. PubMed ID: 16182222
[TBL] [Abstract][Full Text] [Related]
55. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
56. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
57. A phase II study of primary reirradiation in squamous cell carcinoma of head and neck.
Langendijk JA; Kasperts N; Leemans CR; Doornaert P; Slotman BJ
Radiother Oncol; 2006 Mar; 78(3):306-12. PubMed ID: 16524634
[TBL] [Abstract][Full Text] [Related]
58. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review.
Tagliaferri L; Bussu F; Fionda B; Catucci F; Rigante M; Gambacorta MA; Autorino R; Mattiucci GC; Miccichè F; Placidi E; Balducci M; Galli J; Paludetti G; Kovacs G; Valentini V
Tumori; 2017 Nov; 103(6):516-524. PubMed ID: 28291904
[TBL] [Abstract][Full Text] [Related]
59. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.
Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM
Tumori; 2015; 101(5):585-92. PubMed ID: 26108237
[TBL] [Abstract][Full Text] [Related]
60. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.
Phan J; Sio TT; Nguyen TP; Takiar V; Gunn GB; Garden AS; Rosenthal DI; Fuller CD; Morrison WH; Beadle B; Ma D; Zafereo ME; Hutcheson KA; Kupferman ME; William WN; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):30-41. PubMed ID: 27325480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
